BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 32500585)

  • 21. Could the human papillomavirus vaccine prevent recurrence of ano-genital warts?: a systematic review and meta-analysis.
    Husein-ElAhmed H
    Int J STD AIDS; 2020 Jun; 31(7):606-612. PubMed ID: 32438856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
    Lurie S; Mizrachi Y; Chodick G; Katz R; Schejter E
    Gynecol Oncol; 2017 Aug; 146(2):299-304. PubMed ID: 28602548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.
    Rob F; Tachezy R; Pichlík T; Rob L; Kružicová Z; Hamšíková E; Šmahelová J; Hercogová J
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.
    Chelimo C; Wouldes TA; Cameron LD; Elwood JM
    J Infect; 2013 Mar; 66(3):207-17. PubMed ID: 23103285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
    Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK
    Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus typing in reporting of condyloma.
    Sturegård E; Johansson H; Ekström J; Hansson BG; Johnsson A; Gustafsson E; Dillner J; Forslund O
    Sex Transm Dis; 2013 Feb; 40(2):123-9. PubMed ID: 23324975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB; Legler A; Hanchate A
    Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing the health burden of HPV infection through vaccination.
    Soper D
    Infect Dis Obstet Gynecol; 2006; 2006 Suppl():83084. PubMed ID: 16967913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What can surveillance of genital warts tell us?
    Fairley CK; Donovan B
    Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quadrivalent human papillomavirus vaccine.
    Barr E; Tamms G
    Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM; Heywood A; Heley S
    Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Could the human papillomavirus recombinant vaccine be a new valid approach in the management of ano-genital warts?
    Sarro A; Airoldi C; Pedicini A; Di Tullio E; Pecere A
    Ann Ig; 2022; 34(6):656-658. PubMed ID: 34904623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
    Malinova M
    Akush Ginekol (Sofiia); 2015; 54 Suppl 1():25-31. PubMed ID: 26137767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
    Denecke A; Iftner T; Iftner A; Riedle S; Ocak M; Luyten A; Üye I; Tunc K; Petry KU
    BMC Infect Dis; 2021 Jul; 21(1):634. PubMed ID: 34215215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus and vaccination.
    Huang CM
    Mayo Clin Proc; 2008 Jun; 83(6):701-6; quiz 706-7. PubMed ID: 18533087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention.
    Forcier M; Musacchio N
    Dermatol Ther; 2010; 23(5):458-76. PubMed ID: 20868401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women.
    Brotons M; Monfil L; Roura E; Duarte-Salles T; Casabona J; Urbiztondo L; Cabezas C; Bosch FX; de Sanjosé S; Bruni L
    Prev Med; 2020 Sep; 138():106166. PubMed ID: 32565118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPV vaccine update: new indications and controversies.
    Mendoza N; Hernandez PO; Tyring SK
    Skin Therapy Lett; 2011 Sep; 16(8):1-3. PubMed ID: 22089414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
    Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
    Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.